InMed Pharmaceuticals Inc (IN)

$0.30CAD

+$0.30 (+30.00%)

today (15 min delay)

About IN

InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

CEO

Eric A. Adams

Headquarters

Canada

Employees

12

Revenue (TTM)

0

Gross Profit

Earnings

-14.62%

Cash

$9.89M

Debt

$456K

IN related news

    Popular on Wealthsimple

      Investing on autopilot

      Invest in an intelligent portfolio of low-fee funds that are designed to meet your financial goals.

      • Low Fees - Pay an annual management fee of 0.50% (or 0.40% for accounts over $100K)

      • Stay on track - We'll instantly rebalance your portfolio and put your stock dividends back to work, earning you more

      • Human advice - We're loved for our technology. But we also have smart people to answer any questions or give advice when you need it.

      • Easy access - Manage your accounts from anywhere with our award-winning website and mobile app

      Clock

      Start investing in 5 minutes

      1. Answer a few questions about your goals and risk tolerance
      2. We'll recommend a portfolio that's right for you
      3. Connect your bank account and make a deposit

      By clicking "Get started", you agree to Wealthsimple's Terms of Use and Privacy Policy.

      Products
      Features
      Resources
      Pricing
      Country
      Language
      Follow
      Download

      We provide investment services and other financial products through several affiliates. Our Invest and Smart Savings products are offered by Wealthsimple Inc., a registered portfolio manager in each province and territory of Canada. Our Trade and Save products are offered by Canadian ShareOwner Investments Inc. (ShareOwner), a registered investment dealer in each province and territory of Canada. Some clients of Wealthsimple for Advisors have accounts with Wealthsimple Advisor Services Inc. (WASI), a registered mutual fund dealer in each province and territory of Canada. Our Cash product is offered by Wealthsimple Payments Inc., a FINTRAC registered money services business. Our SimpleTax product is offered by SimpleTax Software Inc.

      ShareOwner is a member of the Investment Industry Regulatory Organization of Canada (www.iiroc.ca). Customer accounts are protected by the Canadian Investor Protection Fund within specified limits. A brochure describing the nature and limits of coverage is available upon request or at (www.cipf.ca).

      WASI is a member of the Mutual Fund Dealers Association of Canada and a member of the MFDA Investor Protection Corporation.

      With any investment, your capital is at risk. The value of your portfolio with Wealthsimple can go down as well as up and you may get back less than you invest. Past performance is no guarantee of future results. Read our (investment risk disclosure) for more information.

      By using this website, you accept our (Terms of Use) and (Privacy Policy). Copyright 2020 Wealthsimple Technologies Inc. Market data by Xignite.

      IIROC Member CIPF Member MFDA Member